12748243

Source:http://linkedlifedata.com/resource/pubmed/id/12748243

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0034897, umls-concept:C0684249, umls-concept:C1122962, umls-concept:C1512612
pubmed:issue	12
pubmed:dateCreated	2003-6-13
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/12748243-12748244
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Epidermal Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Quinazolines, http://linkedlifedata.com/resource/pubmed/chemical/gefitinib
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0732-183X
pubmed:author	pubmed-author:ArteagaCarlos LCL, pubmed-author:JohnsonDavid HDH
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	21
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2227-9
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:12748243-Animals, pubmed-meshheading:12748243-Antineoplastic Agents, pubmed-meshheading:12748243-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:12748243-Clinical Trials, Phase II as Topic, pubmed-meshheading:12748243-Epidermal Growth Factor, pubmed-meshheading:12748243-Humans, pubmed-meshheading:12748243-Lung Neoplasms, pubmed-meshheading:12748243-Quinazolines, pubmed-meshheading:12748243-Randomized Controlled Trials as Topic, pubmed-meshheading:12748243-Survival Rate
pubmed:year	2003
pubmed:articleTitle	Gefitinib in recurrent non-small-cell lung cancer: an IDEAL trial?
pubmed:publicationType	Editorial, Comment